155 related articles for article (PubMed ID: 32733070)
21. Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study.
Spence T; Stickle N; Yu C; Chow H; Feilotter H; Lo B; McCready E; Sadikovic B; Siu LL; Bedard PL; Stockley TL
Curr Oncol; 2019 Dec; 26(6):e717-e732. PubMed ID: 31896942
[TBL] [Abstract][Full Text] [Related]
22. One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants.
Gutowska-Ding MW; Deans ZC; Roos C; Matilainen J; Khawaja F; Brügger K; Ahn JW; Boustred C; Patton SJ
Eur J Hum Genet; 2020 Feb; 28(2):202-212. PubMed ID: 31570784
[TBL] [Abstract][Full Text] [Related]
23. Family-Based Next-Generation Sequencing Study Identifies an
Bandari AK; Bhat S; Archana MV; Yadavalli S; Patel K; Rajagopalan P; Madugundu AK; Madkaikar M; Reddy K; Muthusamy B; Pandey A
OMICS; 2019 May; 23(5):285-290. PubMed ID: 31100039
[TBL] [Abstract][Full Text] [Related]
24. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
[TBL] [Abstract][Full Text] [Related]
25. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases.
Al-Mousa H; Abouelhoda M; Monies DM; Al-Tassan N; Al-Ghonaium A; Al-Saud B; Al-Dhekri H; Arnaout R; Al-Muhsen S; Ades N; Elshorbagi S; Al Gazlan S; Sheikh F; Dasouki M; El-Baik L; Elamin T; Jaber A; Kheir O; El-Kalioby M; Subhani S; Al Idrissi E; Al-Zahrani M; Alhelale M; Alnader N; Al-Otaibi A; Kattan R; Al Abdelrahman K; Al Breacan MM; Bin Humaid FS; Wakil SM; Alzayer F; Al-Dusery H; Faquih T; Al-Hissi S; Meyer BF; Hawwari A
J Allergy Clin Immunol; 2016 Jun; 137(6):1780-1787. PubMed ID: 26915675
[TBL] [Abstract][Full Text] [Related]
26. Utility of next generation sequencing in clinical primary immunodeficiencies.
Raje N; Soden S; Swanson D; Ciaccio CE; Kingsmore SF; Dinwiddie DL
Curr Allergy Asthma Rep; 2014 Oct; 14(10):468. PubMed ID: 25149170
[TBL] [Abstract][Full Text] [Related]
27. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies.
Picard C; Fischer A
Eur J Immunol; 2014 Oct; 44(10):2854-61. PubMed ID: 25154746
[TBL] [Abstract][Full Text] [Related]
28. Diagnostics of Hereditary Connective Tissue Disorders by Genetic Next-Generation Sequencing.
Pope MK; Ratajska A; Johnsen H; Rypdal KB; Sejersted Y; Paus B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):783-790. PubMed ID: 31638417
[No Abstract] [Full Text] [Related]
29. [Application of copy number variation analysis based on raw data of next-generation sequencing in the molecular diagnosis for primary immunodeficiency disease].
Xia Y; Zhu XN; Yang J
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):917-921. PubMed ID: 31795557
[No Abstract] [Full Text] [Related]
30. Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.
Sogkas G; Dubrowinskaja N; Schütz K; Steinbrück L; Götting J; Schwerk N; Baumann U; Grimbacher B; Witte T; Schmidt RE; Atschekzei F
Int Arch Allergy Immunol; 2022; 183(3):337-349. PubMed ID: 34619682
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy of a next-generation sequencing gene panel for primary immunodeficiency diagnostics.
Rae W; Ward D; Mattocks C; Pengelly RJ; Eren E; Patel SV; Faust SN; Hunt D; Williams AP
Clin Genet; 2018 Mar; 93(3):647-655. PubMed ID: 29077208
[TBL] [Abstract][Full Text] [Related]
33. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
Sturm AC; Truty R; Callis TE; Aguilar S; Esplin ED; Garcia S; Haverfield EV; Morales A; Nussbaum RL; Rojahn S; Vatta M; Rader DJ
JAMA Cardiol; 2021 Aug; 6(8):902-909. PubMed ID: 34037665
[TBL] [Abstract][Full Text] [Related]
34. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
Lee J; Lee C; Ki CS; Lee J
Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
[TBL] [Abstract][Full Text] [Related]
35. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach.
Burillo-Sanz S; Montes-Cano MA; García-Lozano JR; Ortiz-Fernández L; Ortego-Centeno N; García-Hernández FJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; Rosa Juliá M; Solans R; Blanco R; Barnosi-Marín AC; Gómez De la Torre R; Fanlo P; Rodríguez-Carballeira M; Rodríguez-Rodríguez L; Camps T; Castañeda S; Alegre-Sancho JJ; Martín J; González-Escribano MF
Sci Rep; 2017 Aug; 7(1):8453. PubMed ID: 28814775
[TBL] [Abstract][Full Text] [Related]
36. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
37. Reporting practices for variants of uncertain significance from next generation sequencing technologies.
Vears DF; Sénécal K; Borry P
Eur J Med Genet; 2017 Oct; 60(10):553-558. PubMed ID: 28774848
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed Reference Materials as Controls for Diagnostic Next-Generation Sequencing: A Pilot Investigating Applications for Hypertrophic Cardiomyopathy.
Kudalkar EM; Almontashiri NA; Huang C; Anekella B; Bowser M; Hynes E; Garlick R; Funke BH
J Mol Diagn; 2016 Nov; 18(6):882-889. PubMed ID: 27639548
[TBL] [Abstract][Full Text] [Related]
39. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories.
Weiss MM; Van der Zwaag B; Jongbloed JD; Vogel MJ; Brüggenwirth HT; Lekanne Deprez RH; Mook O; Ruivenkamp CA; van Slegtenhorst MA; van den Wijngaard A; Waisfisz Q; Nelen MR; van der Stoep N
Hum Mutat; 2013 Oct; 34(10):1313-21. PubMed ID: 23776008
[TBL] [Abstract][Full Text] [Related]
40. Validation of copy number variation analysis for next-generation sequencing diagnostics.
Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
